Why the study?
Hydroxychloroquine has established anti-inflammatory and immunomodulatory effects, prompting investigation into its impact and underlying mechanisms in fructose-induced metabolic syndrome.
Does hydroxychloroquine improve metabolic and inflammatory markers in a rat model of fructose-induced metabolic syndrome?
Does hydroxychloroquine improve metabolic and inflammatory markers in a rat model of fructose-induced metabolic syndrome?
In a rat model of fructose-induced metabolic syndrome, hydroxychloroquine improved metabolic parameters, inflammatory markers, and pancreatic histology.
This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Hydroxychloroquine (HCQ) is used in the treatment of malaria and rheumatoid arthritis for a long time. Its effects on inflammation and immune modulation were noted. AIM: This study aims to investigate the effects of HCQ in fructose-induced metabolic syndrome and to explore its possible mechanisms. METHODS AND MATERIALS: Sixty male Sprague-Dawley rats were divided into Group I (negative control), Group II fed on high-fructose diet, and Group III fed on high fructose and subdivided into Group III-a (HCQ 50 mg/kg), Group III-b (HCQ 100 mg/kg), Group III-c (HCQ 200 mg/kg), and Group III-d (metformin 100 mg/kg). Body weight, blood glucose, liver enzymes, and lipid profile were measured. Insulin level, homeostatic model assessment (HOMA), soluble-intercellular adhesion molecule, and vascular cell adhesion molecule were assayed. Tumor necrosis factor (TNF)-α, adipokines (leptin, resistin, and adiponectin), and histological examination of pancreas were assessed. RESULTS: HCQ induces good effects on lipid profile and improves significantly HOMA, endothelial stress markers, and adiponectin, and reduces leptin and TNF-α levels. In addition, significant improvement in structural changes was noted in pancreas with different doses of HCQ. CONCLUSION: Favorable effects of HCQ in fructose-induced metabolic syndrome are promising and can be used early in those at risk of diabetes.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in rat metabolic syndrome model; should not change clinical practice.
No takes yet. Share an insight, caveat, or question.
Shata et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: